RNAC
Cartesian Therapeutics Inc.
$9.70
+$0.38(+4.02%)
44
Overall
60
Value
20
Tech
52
Quality
Market Cap
$253.26M
Volume
30.50K
52W Range
$8.46 - $26.50
Target Price
$36.43
EPS Estimates Overview
| Current Quarter | $-0.81 | Next Quarter | $-0.79 |
| Current Year | $-2.11 | Next Year | $-3.49 |
| QoQ Growth | +2.5% | YoY Growth | -65.4% |
| 3Y EPS CAGR | -173.1% | Target Price | $36.43 |
| Consensus | Buy | Upside | +275.8% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RNAC | $9.70 | +4.0% | 30.50K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Cartesian Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW